Omega Diagnostics, LLC

Omega Diagnostics, LLC was paid $8.87M by Medicaid between Jan 2018 and Dec 2023, across 51 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 81% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Louisiana

Rank by total paid#8 of 66

Median peer was paid$253K

This provider vs. median35×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	8,700	$33K
2019	8,667	$29K
2020	99,627	$2.42M
2021	406,398	$4.93M
2022	153,458	$1.38M
2023	10,114	$72K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	81%	365,061	100,476	$7.16M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	17%	283,797	72,990	$1.46M
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	138	135	$47K
87070		<1%	4,011	3,424	$24K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	334	280	$17K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	711	487	$14K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	3,249	2,855	$13K
80053	Comprehensive metabolic panel	<1%	3,136	2,653	$12K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	295	260	$10K
80061	Lipid panel	<1%	1,575	1,412	$9K
36415	Collection of venous blood by venipuncture	<1%	7,063	6,217	$8K
80050	General health panel	<1%	316	292	$8K

39 more codes

87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	270	$8K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	268	$8K
84443	Thyroid stimulating hormone (TSH)	<1%	1,391	$8K
87581		<1%	282	$7K
87486		<1%	282	$7K
87086	Culture, bacterial; quantitative colony count, urine	<1%	1,776	$7K
84439		<1%	918	$4K
83036	Hemoglobin; glycosylated (A1C)	<1%	1,535	$4K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	289	$4K
80048	Basic metabolic panel (calcium, ionized)	<1%	1,467	$4K
87077		<1%	905	$3K
85027		<1%	2,197	$3K
84703		<1%	380	$2K
87205		<1%	863	$2K
84460		<1%	557	$2K
87186		<1%	948	$2K
84450		<1%	545	$2K
83655		<1%	78	$854.85
81001		<1%	935	$660.08
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	42	$550.52
82607		<1%	75	$508.50
87400		<1%	20	$477.60
86769		<1%	15	$442.08
80076		<1%	91	$348.27
81003		<1%	317	$330.67
87075		<1%	39	$300.50
82570		<1%	178	$226.60
82043		<1%	62	$190.12
86140		<1%	68	$180.25
85652		<1%	109	$174.20
83550		<1%	29	$132.37
87631		<1%	70	$127.76
84156		<1%	120	$121.91
87158		<1%	37	$115.18
87088		<1%	23	$104.78
82728		<1%	17	$70.40
80069		<1%	43	$43.40
85610		<1%	21	$19.60
84100		<1%	16	$18.92

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKHARE, VIVEK (CEO)